AG-490
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 200121

CAS#: 133550-30-8

Description: Tyrphostin AG490 is a JAK-2 specific inhibitor, which inhibits phosphorylation of EGFR and signal transducer and activator of transcription 3 [STAT-3], and subsequently reduce invasion and adhesion potential of malignant cells. The hematopoietic cancer c-Kit+, Jak-2+ and non hematopoietic tumors c-Kit+, HER-2+, JAK-2+ can be inhibited by the chemosensitizing agent AG490 causing programmed cell death.


Chemical Structure

img
AG-490
CAS# 133550-30-8

Theoretical Analysis

MedKoo Cat#: 200121
Name: AG-490
CAS#: 133550-30-8
Chemical Formula: C17H14N2O3
Exact Mass: 294.10044
Molecular Weight: 294.3
Elemental Analysis: C, 69.38; H, 4.79; N, 9.52; O, 16.31

Price and Availability

Size Price Availability Quantity
50.0mg USD 250.0 2 Weeks
100.0mg USD 450.0 2 Weeks
200.0mg USD 750.0 2 Weeks
500.0mg USD 1550.0 2 Weeks
1.0g USD 2450.0 2 Weeks
2.0g USD 4450.0 2 Weeks
5.0g USD 6950.0 2 Weeks
Bulk inquiry

Synonym: AG 490; AG490; AG-490; Tyrphostin AG 490

IUPAC/Chemical Name: (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide

InChi Key: TUCIOBMMDDOEMM-RIYZIHGNSA-N

InChi Code: InChI=1S/C17H14N2O3/c18-10-14(8-13-6-7-15(20)16(21)9-13)17(22)19-11-12-4-2-1-3-5-12/h1-9,20-21H,11H2,(H,19,22)/b14-8+

SMILES Code: O=C(NCC1=CC=CC=C1)/C(C#N)=C/C2=CC=C(O)C(O)=C2

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >5 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Product Data:

Biological target: AG490 (Tyrphostin AG490) is a tyrosine kinase inhibitor that inhibits EGFR, Stat-3 and JAK2/3.
In vitro activity: To explore the effect of blocking p-JAK2 on TNF-α-induced apoptosis in MC3T3-E1 cells, cells were pretreated with AG490 (0, 10, 20, and 40 μM), a specific JAK2 inhibitor, for 30 min before incubation with TNF-α (20 ng/ml, 48 h). Then, flow cytometry was performed after Annexin V and PI labeling. The results showed that AG490 significantly increased the percentage of apoptotic cells (Figs. 3A and B). Western blot analysis was used to detect p-JAK2, JAK2, and Cl-PARP expression. JAK2 phosphorylation decreased and reached the lowest point at 40 μM concentration. Meanwhile, the level of Cl-PARP increased (Figs. 3C–E). These results indicate that JAK2-blockage increases TNF-α-induced apoptosis in MC3T3-E1 cell. Reference: Pharmazie. 2020 Jun 1;75(6):255-260. https://pubmed.ncbi.nlm.nih.gov/32539921/
In vivo activity: Besides the effect of AG490 on neuroprotection against apoptosis, this study also observed the alternations of neurotrophins mediated by the inhibitor for neural repairment. The results from ELISA tests revealed that the i.p. injection of AG490 could increase the BNDF level from serum and brain tissue of MCAO mice (Figure 5a,b). Meanwhile, this study found the higher expression of BNDF (p < .05), neurotrophin‐3 (NT3), and also the neurotrophin receptor TrkB in the brain tissue (Figure 5c–e) in vivo. This evidence suggests that AG490 served as a pluripotent drug for neuroprotection in addition to its antiapoptotic activity. Reference: Brain Behav. 2021 Jan; 11(1): e01911. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821583/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 45.81 155.66
DMSO:PBS (pH 7.2) (1:10) 0.1 0.34
DMF 25.0 84.95
Ethanol 7.3 24.8

Preparing Stock Solutions

The following data is based on the product molecular weight 294.3 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Ni Y, Zhang H, Zhang J, Li Z, Li Z. Inhibition of JAK2 by AG490 promotes TNF-α-induced apoptosis by inhibiting autophagy in MC3T3-E1 cells. Pharmazie. 2020 Jun 1;75(6):255-260. doi: 10.1691/ph.2020.0375. PMID: 32539921. 2. Zhou Y, Sun Y, Hou W, Ma L, Tao Y, Li D, Xu C, Bao J, Fan W. The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro. Int J Mol Med. 2020 Jul;46(1):191-200. doi: 10.3892/ijmm.2020.4592. Epub 2020 Apr 29. PMID: 32377718; PMCID: PMC7255460. 3. Fan L, Zhou L. AG490 protects cerebral ischemia/reperfusion injury via inhibiting the JAK2/3 signaling pathway. Brain Behav. 2021 Jan;11(1):e01911. doi: 10.1002/brb3.1911. Epub 2020 Oct 23. PMID: 33098244; PMCID: PMC7821583. 4. Tan G, Jiang L, Li G, Bai K. ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948062. doi: 10.1177/1533033820948062. PMID: 33063634; PMCID: PMC7580129.
In vitro protocol: 1. Ni Y, Zhang H, Zhang J, Li Z, Li Z. Inhibition of JAK2 by AG490 promotes TNF-α-induced apoptosis by inhibiting autophagy in MC3T3-E1 cells. Pharmazie. 2020 Jun 1;75(6):255-260. doi: 10.1691/ph.2020.0375. PMID: 32539921. 2. Zhou Y, Sun Y, Hou W, Ma L, Tao Y, Li D, Xu C, Bao J, Fan W. The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro. Int J Mol Med. 2020 Jul;46(1):191-200. doi: 10.3892/ijmm.2020.4592. Epub 2020 Apr 29. PMID: 32377718; PMCID: PMC7255460.
In vivo protocol: 1. Fan L, Zhou L. AG490 protects cerebral ischemia/reperfusion injury via inhibiting the JAK2/3 signaling pathway. Brain Behav. 2021 Jan;11(1):e01911. doi: 10.1002/brb3.1911. Epub 2020 Oct 23. PMID: 33098244; PMCID: PMC7821583. 2. Tan G, Jiang L, Li G, Bai K. ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948062. doi: 10.1177/1533033820948062. PMID: 33063634; PMCID: PMC7580129.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: DU AL, Ji TL, Yang B, Cao JF, Zhang XG, Li Y, Pan S, Zhang B, Hu ZB, Zeng XW.  Neuroprotective effect of AG490 in experimental traumatic brain injury of rats. Chin Med J (Engl). 2013 Aug;126(15):2934-7. PubMed PMID: 23924471.

AG-490

50.0mg / USD 250.0


Additional Information

AG490 greatly inhibited osteoclast apoptosis. AG490 stimulated the phosphorylation of Akt and ERK. Adenovirus-mediated expression of dominant negative (DN)-Akt and DN-Ras in osteoclasts inhibited the survival of osteoclasts despite the presence of AG490. Cytochrome c release during osteoclast apoptosis was inhibited by AG490 treatment, but this effect was inhibited in the presence of LY294002 or U0126. AG490 suppressed the proapoptotic proteins Bad and Bim, which was inhibited in osteoclasts infected with DN-Akt and DN-Ras adenovirus. In addition, constitutively active MEK and myristoylated-Akt adenovirus suppressed the cleavage of pro-caspase-9 and -3 and inhibited osteoclast apoptosis induced by etoposide. Taken together, our results suggest that AG490 inhibited cytochrome c release into the cytosol at least partly by inhibiting the pro-apoptotic proteins Bad and Bim, which in turn suppressed caspase-9 and -3 activation, thereby inhibiting osteoclast apoptosis.